After decades of a single approach—replacement factor infusion—the treatment landscape for the management of hemophilia is rapidly evolving and numerous exciting research avenues are being...
Gene therapy in hemophilia featured heavily at the World Federation of Hemophilia Global Forum held in Montréal November 13 to 14, 2019. Glenn Pierce, MD,...
Evolution of Treatment Products—the much anticipated second module in the Treatment Products eLearning program—has launched! This module explains the evolution of products for the treatment...
Enhance your knowledge of emerging gene therapy in hemophilia and claim up to 1.75 AMA PRA Category 1 Credits™ in 2019 with Clinical Advances in...
The World Federation of Hemophilia (WFH) is pleased to announce the launch of the fifth and final activity in Clinical Advances in Gene Therapy for...
The World Federation of Hemophilia (WFH) is proud to announce the launch of Activity #4 in Clinical Advances in Gene Therapy for Hemophilia, an online...
The World Federation of Hemophilia (WFH) is proud to announce the launch of the next activity in Clinical Advances in Gene Therapy for Hemophilia, an...
The World Federation of Hemophilia (WFH) is proud to announce the launch of Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education...
Luisa Durante, Program Development Manger, World Federation of Hemophilia (WFH) gathered people with von Willebrand disease (VWD) at the Resource Centre of the WFH 2018...
At the World Federation of Hemophilia (WFH) World Congress in Orlando, U.S.A, Andra James (U.S.A.) chaired a discussion between Amy Griffith (Canada), Peter Noun (Lebanon),...